Obligation Allergan Finance SCS 0.5% ( XS1622630132 ) en EUR

Allergan Finance SCS

100 % ▲

Irlande

XS1622630132 ( en EUR )

0.5% par an ( paiement annuel )

31/05/2021 - Obligation échue

Prospectus brochure de l'obligation Allergan Funding SCS XS1622630132 en EUR 0.5%, échue

100 000 EUR

210 982 000 EUR

018489AC8

Allergan Funding SCS est une entité de financement créée par Allergan (aujourd'hui propriété d'AbbVie) pour soutenir le développement et le lancement de produits pharmaceutiques et dispositifs médicaux.

L'Obligation émise par Allergan Finance SCS ( Irlande ) , en EUR, avec le code ISIN XS1622630132, paye un coupon de 0.5% par an.
Le paiement des coupons est annuel et la maturité de l'Obligation est le 31/05/2021

FWP
https://www.sec.gov/Archives/edgar/data/1620554/000119312517179...
FWP 1 d356336dfwp.htm FWP
Free Writing Prospectus
Filed pursuant to Rule 433
Registration Statement No. 333-202168-02
ALLERGAN FUNDING SCS
Pricing Term Sheet
Offering of
750,000,000 0.500% Notes due 2021
700,000,000 1.250% Notes due 2024
550,000,000 2.125% Notes due 2029
700,000,000 Floating Rate Notes due 2019
(the "Notes Offering")
This pricing term sheet relates only to the Notes Offering and should be read together with the preliminary prospectus
supplement dated May 23, 2017 relating to the Notes Offering (the "Notes Preliminary Prospectus Supplement"), the
accompanying prospectus dated February 19, 2015 and the documents incorporated and deemed to be incorporated by
reference therein. Certain capitalized terms used in this pricing term sheet that are not defined herein have the respective
meanings given to such terms in the Notes Preliminary Prospectus Supplement.
Issuer:
Allergan Funding SCS (formerly known as Actavis Funding SCS), a common
limited partnership (société en commandite simple) organized under the laws of the
Grand Duchy of Luxembourg, having its registered office at 46A, avenue
J.F. Kennedy, L-1855 Luxembourg, Grand Duchy of Luxembourg, registered with
the Luxembourg Register of Commerce and Companies under number B187.310
Gross Proceeds to Issuer:
2,689,784,000
Guarantees:
Warner Chilcott Limited, Allergan Capital S.à r.l. (formerly known as Actavis
Capital S.à r.l.) and Allergan Finance, LLC (formerly known as Actavis, Inc.) will
jointly and severally, irrevocably and unconditionally guarantee the notes on an
unsecured and unsubordinated basis
Aggregate Principal Amount Offered:
750,000,000 aggregate principal amount of 0.500% notes due 2021 (the "2021
notes")
700,000,000 aggregate principal amount of 1.250% notes due 2024 (the "2024
notes")
550,000,000 aggregate principal amount of 2.125% notes due 2029 (the "2029
notes")
700,000,000 aggregate principal amount of floating rate notes due 2019 (the
"floating rate notes")
(The 2021 notes, 2024 notes and 2029 notes, together, the "fixed rate notes" and, the
fixed rate notes and the floating rate notes, together, the "notes")
Listing
The issuer intends to apply to list the notes on the New York Stock Exchange; there
can be no assurance that any such application will be successful or that any such
listing will be granted or maintained
Ranking:
General unsecured
Anticipated Ratings (Moody's / S&P)*
Baa3 (Stable) / BBB (Positive)
Coupon:
2021 notes:
0.500%
2024 notes:
1.250%
2029 notes:
2.125%
Floating rate notes: 3-month EURIBOR plus 0.350% per annum
1 sur 4
19/11/2020 à 09:20

FWP
https://www.sec.gov/Archives/edgar/data/1620554/000119312517179...
Maturity:
2021 notes:
June 1, 2021
2024 notes:
June 1, 2024
2029 notes:
June 1, 2029
Floating rate notes: June 1, 2019
Price to Public:
2021 notes:
99.537% of principal amount
2024 notes:
99.355% of principal amount
2029 notes:
99.465% of principal amount
Floating rate notes: 100.102% of principal amount
Underwriting Discount
2021 notes:
0.300% of principal amount
2024 notes:
0.400% of principal amount
2029 notes:
0.475% of principal amount
Floating rate notes: 0.200% of principal amount
Yield to Maturity for Fixed Rate Notes:
2021 notes:
0.617%
2024 notes:
1.347%
2029 notes:
2.176%
Spread to Benchmark Bund for Fixed Rate 2021 notes:
+109.5 basis points
Notes:
2024 notes:
+138 basis points
2029 notes:
+177.2 basis points
Benchmark Bund for Fixed Rate Notes:
2021 notes:
OBL 0.0% due April 9, 2021
2024 notes:
DBR 1.5% due May 15, 2024
2029 notes:
DBR 0.25% due February 15, 2027
Benchmark Bund Yield for Fixed Rate
2021 notes:
-0.478%
Notes:
2024 notes:
-0.033%
2029 notes:
0.404%
Spread to Mid-Swaps for Fixed Rate
2021 notes:
+52 basis points
Notes:
2024 notes:
+87 basis points
2029 notes:
+115 basis points
Mid-Swaps Yield for Fixed Rate Notes:
2021 notes:
0.097%
2024 notes:
0.477%
2029 notes:
1.026%
Interest Payment Date:
2021 notes:
Annually on June 1 of each year, beginning June 1, 2018
2024 notes:
Annually on June 1 of each year, beginning June 1, 2018
2029 notes:
Annually on June 1 of each year, beginning June 1, 2018
Floating rate notes: Quarterly on June 1, September 1, December 1 and March 1
of each year, beginning September 1, 2017
2 sur 4
19/11/2020 à 09:20

FWP
https://www.sec.gov/Archives/edgar/data/1620554/000119312517179...
Record Date:
2021 notes:
On May 15 of each year
2024 notes:
On May 15 of each year
2029 notes:
On May 15 of each year
Floating rate notes:
15th calendar day immediately preceding any interest
payment date (whether or not a business day)
Optional Redemption Fixed Rate Notes
2021 notes:
B+20 basis points prior to May 1, 2021
Make-Whole Call:
2024 notes:
B+25 basis points prior to March 1, 2024
2029 notes:
B+30 basis points prior to March 1, 2029
Optional Redemption Fixed Rate Notes
2021 notes:
On or after May 1, 2021 (1 month prior to the maturity date
Par Call:
for the 2021 notes)
2024 notes:
On or after March 1, 2024 (3 months prior to the maturity
date for the 2024 notes)
2029 notes:
On or after March 1, 2029 (3 months prior to the maturity
date for the 2029 notes)
Trade Date:
May 23, 2017
Settlement:
May 26, 2017 (T+3)
CUSIP / ISIN:
2021 notes:
018489 AC8 / XS1622630132
2024 notes:
018489 AB0 / XS1622624242
2029 notes:
018489 AA2 / XS1622621222
Floating rate notes:
018489 AD6 / XS1622634126
Denominations:
100,000 and increments of 1,000 in excess thereof
Joint Book-Running Managers:
Morgan Stanley & Co. International plc
Barclays Bank PLC
BNP Paribas
HSBC Bank plc
Additional Joint Book-Running Managers: Citigroup Global Markets Limited
Merrill Lynch International
Mizuho International plc
Co-Managers:
DNB Markets
MUFG Securities EMEA plc
SMBC Nikko Capital Markets Limited
TD Securities (USA) LLC
Wells Fargo Securities International Limited
*A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any
time.
The issuer has filed a registration statement (including a prospectus) with the Securities and Exchange
Commission (the "SEC") for the offering to which this communication relates. Before you invest, you should read the
prospectus in that registration statement and the related prospectus supplement and other
3 sur 4
19/11/2020 à 09:20

FWP
https://www.sec.gov/Archives/edgar/data/1620554/000119312517179...
documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may
get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any
underwriter or any dealer participating in the Notes Offering will arrange to send you the prospectus and related
prospectus supplement if you request it by calling (toll free): Morgan Stanley & Co. International plc at
1-866-718-1649, Barclays Bank PLC at 1-888-603-5847, BNP Paribas at 1-800-854-5674 or HSBC Bank plc at
1-866-811-8049.
4 sur 4
19/11/2020 à 09:20